MedPharm is an end-to-end contract service provider of topical product development and manufacturing, supporting early-phase research, formulation development, and in vitro testing services in addition to both clinical and commercial manufacturing. Since 1999, MedPharm has specialized in reducing risk through its unique, industry-leading in vitro testing and research biology models. Well-established as the global leader in product development for dermal/transdermal, lung and nasal, mucosal membrane, ungual, otic, and ophthalmic delivery, MedPharm has locations in the United Kingdom and the United States, including a new 97,000 sq. ft. state-of-the-art facility in Durham, NC and is recognized globally for its regulatory and technical expertise.